These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32879651)

  • 1. Identification of New Targets and the Virtual Screening of Lignans against Alzheimer's Disease.
    Dos Santos Maia M; Rodrigues GCS; de Sousa NF; Scotti MT; Scotti L; Mendonça-Junior FJB
    Oxid Med Cell Longev; 2020; 2020():3098673. PubMed ID: 32879651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach.
    Ambure P; Bhat J; Puzyn T; Roy K
    J Biomol Struct Dyn; 2019 Mar; 37(5):1282-1306. PubMed ID: 29578387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual Screening and the In Vitro Assessment of the Antileishmanial Activity of Lignans.
    Maia MDS; Silva JPRE; Nunes TAL; Sousa JMS; Rodrigues GCS; Monteiro AFM; Tavares JF; Rodrigues KADF; Mendonça-Junior FJB; Scotti L; Scotti MT
    Molecules; 2020 May; 25(10):. PubMed ID: 32408657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer's disease.
    Shukla R; Singh TR
    J Biomol Struct Dyn; 2020 Jan; 38(1):248-262. PubMed ID: 30688165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual Screening of Novel and Selective Inhibitors of Protein Tyrosine Phosphatase 1B over T-Cell Protein Tyrosine Phosphatase Using a Bidentate Inhibition Strategy.
    Chen X; Gan Q; Feng C; Liu X; Zhang Q
    J Chem Inf Model; 2018 Apr; 58(4):837-847. PubMed ID: 29608303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacophore-based virtual screening of catechol-o-methyltransferase (COMT) inhibitors to combat Alzheimer's disease.
    Patel CN; Georrge JJ; Modi KM; Narechania MB; Patel DP; Gonzalez FJ; Pandya HA
    J Biomol Struct Dyn; 2018 Nov; 36(15):3938-3957. PubMed ID: 29281938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel class I and class IIb histone deacetylase inhibitor for Alzheimer's disease therapeutics.
    Gupta R; Ambasta RK; Kumar P
    Life Sci; 2020 Sep; 256():117912. PubMed ID: 32504755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of multitarget-directed ligands against Alzheimer's disease through systematic prediction of chemical-protein interactions.
    Fang J; Li Y; Liu R; Pang X; Li C; Yang R; He Y; Lian W; Liu AL; Du GH
    J Chem Inf Model; 2015 Jan; 55(1):149-64. PubMed ID: 25531792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biaryl scaffold-focused virtual screening for anti-aggregatory and neuroprotective effects in Alzheimer's disease.
    Khalid S; Zahid MA; Ali H; Kim YS; Khan S
    BMC Neurosci; 2018 Nov; 19(1):74. PubMed ID: 30424732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors.
    Park H; Bhattarai BR; Ham SW; Cho H
    Eur J Med Chem; 2009 Aug; 44(8):3280-4. PubMed ID: 19269068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of C-glycosylation on anti-diabetic, anti-Alzheimer's disease and anti-inflammatory potential of apigenin.
    Choi JS; Islam MN; Ali MY; Kim EJ; Kim YM; Jung HA
    Food Chem Toxicol; 2014 Feb; 64():27-33. PubMed ID: 24291393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of ligand-based pharmacophore modeling and docking approach to find novel acetylcholinesterase inhibitors for treating Alzheimer's.
    Dhanjal JK; Sharma S; Grover A; Das A
    Biomed Pharmacother; 2015 Apr; 71():146-52. PubMed ID: 25960230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematically Characterize the Anti-Alzheimer's Disease Mechanism of Lignans from
    Wei M; Liu Y; Pi Z; Li S; Hu M; He Y; Yue K; Liu T; Liu Z; Song F; Liu Z
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30934777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Synthesis, and Biological Evaluation of Orally Available First-Generation Dual-Target Selective Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5) for the Treatment of Alzheimer's Disease.
    Mao F; Wang H; Ni W; Zheng X; Wang M; Bao K; Ling D; Li X; Xu Y; Zhang H; Li J
    ACS Chem Neurosci; 2018 Feb; 9(2):328-345. PubMed ID: 29068218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's disease.
    Zuccarello E; Acquarone E; Calcagno E; Argyrousi EK; Deng SX; Landry DW; Arancio O; Fiorito J
    Biochem Pharmacol; 2020 Jun; 176():113818. PubMed ID: 31978378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular docking and molecular dynamics approach to identify potential compounds in
    Tung BT; Hang TTT; Kim NB; Nhung NH; Linh VK; Thu DK
    J Complement Integr Med; 2022 Dec; 19(4):955-965. PubMed ID: 35621378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Silico Molecular Docking Analysis of Karanjin against Alzheimer's and Parkinson's Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and Therapy.
    Gnanaraj C; Sekar M; Fuloria S; Swain SS; Gan SH; Chidambaram K; Rani NNIM; Balan T; Stephenie S; Lum PT; Jeyabalan S; Begum MY; Chandramohan V; Thangavelu L; Subramaniyan V; Fuloria NK
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of High-affinity Small Molecules Targeting Gamma Secretase for the Treatment of Alzheimer's Disease.
    Ali MA; Vuree S; Goud H; Hussain T; Nayarisseri A; Singh SK
    Curr Top Med Chem; 2019; 19(13):1173-1187. PubMed ID: 31244427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.